PCR-CIT China Chengdu Valves 2016
The foundational Course for Valve Interventions in Greater China
Course in the Asia region on transcatheter valve therapy
Under the joint-organization of PCR, CIT (China Interventional Therapeutics), and West China Hospital of Sichuan University, the second edition of PCR-CIT China Chengdu Valves (PCCV) was held from 4th - 6th November, 2016 in Chengdu, China.
It is organized based on the successful experience of PCR London Valves, under the theme of Transcatheter Aortic Valve Implantation (TAVI). This conference focuses on basic skill training through hands-on practice, live demonstration, academic lectures and case-based discussions.
Transcatheter valve therapy has evolved as an established field in clinical practice, with proved effectiveness of improving survival and quality of life in patients deemed inoperable or at high risk for surgical valve replacement. Over the past twenty years, PCR Organization has been helping the cardiovascular community to share knowledge, experience and practice; they have successfully guided and promoted transcatheter valve therapy stretching from Europe to the West. However, the development of transcatheter valve therapy is still at its preliminary stage in mainland China and the Asia-Pacific region.
The PCCV course helps improve the ability of doctors in China and the Asia-Pacific region to use this technology and hopefully promote its development for the benefits of the patients.
Thank you so much to everyone who attended the 2nd edition of this Course, jointly organised by PCR, CIT (China Interventional Therapeutics), and the West China Hospital of Sichuan University, focusing on transcatheteraortic valve implantation (TAVI).
Goals and Objectives
The primary objectives of the PCCV course are to provide practical training on transcatheter heart valve therapy, especially transcatheter aortic valve implantation (TAVI), in mainland China and the Asia-Pacific region, to teach and improve physicians to use this technology for the benefit of patients in the region. The course also aims at establishing an interactive academic exchange platform between Asian and Western physicians. In between three to five years, it aims to be recognized internationally as the highest academic and educational conferences on TAVI in the Asia-Pacific region.
Who should attend?
The PCCV course is designed for cardiologists who are planning to initiate TAVI projects in their institutions or who have been dedicated to this field. Nevertheless, any doctor who is interested in TAVI and wants to learn the procedure or get updated with the latest advances is welcome to attend this meeting.
Please click here to consult the list of Board members for the PCR-CIT China Chengdu Valves 2016 course edition.
Discover the PCR-CIT China Chengdu Valves 2016 Programme.
Get a Glimpse of PCR China Chengdu Valves 2016 course edition and watch the opening ceremony vide.
Slide presentations / lectures and other course resources, which include LIVE cases and session videos, will be available for FREE on PCRonline.
Get a glimpse of this meeting, consult the PCCV 2016 photo album on Facebook.